This could be it! A virus that hunts out and destroys cells that have hyperactive biochemical pathways common to many cancers. The more active the pathway, the worse the cancer, the greater the kill rate of the virus!
Here's a link if you want more info:
bio.com
Share price is ~$1.5 US for a company that has huge potential of getting this cure on the market fast.
Clinical trials for this cancer cure (phase I and II) start this winter in Calgary. Should see a good spike then.
The company has other drugs which adds diversity.
What do you think?
Good luck to all,
Richard.
p.s. I am a long here and will hold until its above $50! |
